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ABSTRACT 
BACKGROUND 
              Fresh frozen plasma forms the backbone in the management of 
coagulopathies due to liver disease, disseminated intravascular coagulation, 
Thrombotic thrombocytopenic purpura, Coumadin use and major blood loss. 
Wastage of this resource should be avoided or minimized. Hence we conducted this 
prospective study to analyse the stability of coagulation factors in thawed plasma 
that was previously frozen at two different temperatures and now stored at 2°C to 
6°C over 5 days. The study was done at The Department Of Transfusion Medicine, 
The Tamilnadu Dr. MGR Medical University, Guindy, Chennai and at Govt. 
Kilpauk Medical College & Hospital, Chennai. 
OBJECTIVE  
To analyse the coagulation factors V and VIII levels in fresh frozen plasma 
stored at -30°C and at -70°C for a duration of 3 months. 
 To evaluate whether the thawed plasma stored for a considerable time at 2°C 
to 6°C is appropriate for therapeutic use. 
MATERIALS AND METHODS 
Forty samples of fresh plasma were collected, baseline values of fibrinogen, 
factor V, factor VIII, PT and APTT measured and were then divided into two 
groups, frozen and stored at -30°C and -70°C respectively for 3 months. They were 
then thawed at 37°C, and stored at 2°C to 6°C for 5 days. The parameters were 
measured at regular intervals during the period of storage of thawed plasma. 
  
OBSERVATIONS 
In both the groups, even the coagulation values measured immediately after 
thawing (day 0) showed a statistically significant difference compared to baseline. 
This significance extended up to day 5. However, all the values of observed 
parameters were within the physiological limits. This shows that the process of 
storage of Fresh Frozen Plasma does cause a decrease in the coagulation factors 
immaterial of the storage temperature, though within therapeutic range. 
Between the groups, the -70°C group performed better in retaining the 
stability of coagulation factors. This was evident in the statistically significant 
difference observed between the groups at 72 hours and 120 hours after thawing and 
storage at 2 to 6°C.  The values observed in the -30°C group was however in the 
hemostatic range. 
Among the factors, fibrinogen was found to be the most stable with lesser 
fluctuations from the baseline values. Factor VIII was observed to be the most labile 
among the observed parameters, decreasing by 28% from the baseline value. Yet, 
the therapeutic measure of atleast 0.5 units/ml as suggested by the European 
Pharmacopoeia was not breached. 
CONCLUSION 
We conclude that the coagulation factors in thawed plasma that was frozen 
previously at -30°C and -70°C, retained its stability when stored at 2°C to 6°C for  
5 days. After thawing, if stored at appropriate temperature, the plasma can be 
utilized up to 5 days, thereby minimizing its wastage. 
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